U.S. Professional Services Stock News

NYSE:AAP
NYSE:AAPSpecialty Retail

Advance Auto Parts Extends NASCAR Deal As Investors Weigh Turnaround Story

Advance Auto Parts renewed its partnership with Team Penske and NASCAR Cup Series champion Ryan Blaney for upcoming NASCAR seasons. The agreement keeps Advance Auto Parts branding on the No. 12 Ford Mustang and at key NASCAR events. The deal includes planned in store appearances and fan engagement events featuring Ryan Blaney. For investors watching NYSE:AAP, this renewed motorsports partnership comes with the stock trading at $51.57. Shares are up 9.6% over the past week, 32.6% year to...
NYSE:IEX
NYSE:IEXMachinery

Has The Recent Pullback In IDEX (IEX) Opened A Valuation Opportunity For Investors

If you are wondering whether IDEX at around US$186.55 is offering fair value or a potential mispricing, you are not alone. The stock has returned 1.3% over the last 7 days, 4.2% year to date and 4.7% over the past year, but this sits alongside a 9.5% decline over the last 30 days and negative 3 and 5 year returns. These mixed returns have kept attention on IDEX, with investors weighing up how its business profile and industry position compare with current expectations. Recent coverage has...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

The Bull Case For Capital Clean Energy Carriers (CCEC) Could Change Following Earnings Jump And Deleveraging Pivot

In early March 2026, Capital Clean Energy Carriers Corp. reported a 36.5% year-on-year rise in Q4 2025 net income, took delivery of its first LCO2/multi-gas carrier Active funded partly by a 12-year ECA-backed loan, and completed the profitable sale of the M/V Buenaventura Express to lower debt. Together, the earnings jump, fleet upgrade into specialized multi-gas capacity, and balance sheet improvement offer a clearer view of how the company is aligning growth with capital discipline. We...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply Puts Culture In Focus As Growth Pressures Persist

Tractor Supply, NasdaqGS:TSCO, is marking the 10th anniversary of its Country Mile recognition program. The company is honoring a record 20 team members for their contributions under the program. More than 750,000 recognition badges were awarded to team members over the past year. Tractor Supply, trading at $44.87, has seen a 38.1% return over the past 5 years, while the past 1 year reflects a 14.6% decline. Shorter term performance has also been softer, with returns of a 2.0% decline over...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Is It Time To Reassess Distribution Solutions Group (DSGR) After The US$29.50 Go Private Proposal

How Distribution Solutions Group's recent share price sets up a valuation check Before getting into detailed valuation work, it helps to understand how Distribution Solutions Group's share price has been behaving and what recent information is shaping expectations. Over the last week, the stock has been relatively steady with a 0.2% decline, but the past month has seen a sharper 12.6% pullback and the year to date return sits at a 7.2% loss, with the last 12 months at a 6.8% loss, even though...
NasdaqGS:LGN
NasdaqGS:LGNConstruction

Legence (LGN) Q3 Revenue Strength Tests Bullish Narratives On Path To Profitability

Legence (LGN) has just posted another busy quarter, with Q3 FY 2025 revenue of US$708.0 million and a small loss, as Basic EPS landed at a US$0.02 loss and net income excluding extra items was a US$1.1 million loss. The company has seen revenue move from US$560.8 million in Q3 FY 2024 to US$708.0 million in Q3 FY 2025. Over the trailing 12 months, revenue reached about US$2.4 billion against a trailing 12 month net loss of US$19.8 million, putting the spotlight squarely on scaling margins...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics Obesity Trial Success Puts Valuation Gap In Focus

Structure Therapeutics (NasdaqGM:GPCR) released highly positive Phase 2 topline data for its oral GLP-1 receptor agonist aleniglipron in obesity and overweight patients. The new results from the ACCESS clinical program show significant weight loss, a compelling safety and tolerability profile, and low discontinuation rates. The company plans to advance aleniglipron into Phase 3 trials based on these Phase 2 outcomes. Structure Therapeutics focuses on small molecule medicines, and...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Offering Value After Recent Share Price Pullback

If you are wondering whether Dolby Laboratories at around US$58 per share offers value or a value trap, the starting point is understanding what the current price actually bakes in. The stock has recently pulled back, with returns of 3.8% over 7 days, 9.7% over 30 days and 8.7% year to date, adding to a 25.9% return over 1 year, 28.6% over 3 years and 38.8% over 5 years. Recent coverage around Dolby has focused on its position in audio and visual technologies and how it fits into broader...
NasdaqGM:ZNTL
NasdaqGM:ZNTLBiotechs

Zentalis Pharmaceuticals (ZNTL) Posts Zero Revenue Challenging Bullish Revenue Recovery Narratives

Zentalis Pharmaceuticals (ZNTL) has just posted its FY 2025 first half results with total revenue at US$0 million, basic EPS at a loss of US$1.05, and net income excluding extraordinary items at a loss of US$75.2 million. This puts the focus firmly on expense control and cash burn. Over the recent periods, the company has seen revenue move from US$40.6 million in the first half of 2024 to US$26.9 million in the second half of 2024, before dropping to zero in the latest half. Half year basic...
NYSE:JBS
NYSE:JBSFood

JBS Index Removal Puts Focus On Valuation Momentum And Dividend Risks

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is Arch Capital Group (ACGL) Still Attractive After Recent Share Price Softness?

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

A Look At Brighthouse Financial (BHF) Valuation After Recent Share Price Weakness

Brighthouse Financial (BHF) is back on investors’ radar after a recent share move. The stock is trading around $59.98, with performance over the past month and past 3 months in focus. See our latest analysis for Brighthouse Financial. Recent price action has softened, with a 90 day share price return of a 7.51% decline and a year to date share price return of a 7.11% decline. However, the 1 year total shareholder return of 4.22% and 3 year total shareholder return of 35.98% indicate that...
NYSE:EG
NYSE:EGInsurance

Everest Group Canada Sale And Rating Review Create Valuation Questions

Everest Group (NYSE:EG) has agreed to sell 100% of Everest Insurance Company of Canada to The Wawanesa Mutual Insurance Company. Following the announcement, AM Best placed Everest Canada’s financial strength and credit ratings under review with negative implications. The proposed transaction is subject to regulatory approvals and closing conditions, adding timing and execution uncertainty for investors and policyholders. Everest Group is a global reinsurance and insurance provider, and its...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s Sales Growth Meets Profitability Strains And Cooling Sentiment

Verra Mobility, NasdaqCM:VRRM, is reporting long term sales growth alongside pressure on free cash flow margins. Recent quarterly results show weaker profitability, prompting questions about investment needs and cost control. Investor sentiment has cooled, with the share price at $13.88 and a 37.8% decline year to date. For shareholders, the story around Verra Mobility is no longer just about sales momentum. The stock is down 37.8% year to date and 31.3% over the past year, with the current...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods (SFD) Is Up 15.4% After Record Profit And Nathan’s Famous Deal - What's Changed

In March 2026, Smithfield Foods reported higher fourth-quarter and full-year 2025 results, issued 2026 guidance for low-single-digit sales growth, announced a quarterly dividend of US$0.3125 per share, and outlined an agreement to acquire the Nathan's Famous packaged meats brand while continuing to evaluate additional M&A opportunities. A key takeaway for investors is Smithfield Foods’ record 2025 operating profit of US$1.30 billion and margin expansion to 8.6%, highlighting improved...
NasdaqGS:SPRO
NasdaqGS:SPROBiotechs

Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives

Spero Therapeutics (SPRO) closed FY 2025 with fourth quarter revenue of US$41.3 million and basic EPS of US$0.56, alongside trailing twelve month revenue of US$66.8 million and EPS of roughly US$0.15 that mark a shift into profitability over the period. Over recent quarters, the company has seen revenue range from US$5.4 million to US$41.3 million with quarterly EPS moving from a loss of about US$0.25 per share at the start of FY 2025 to a profit in the latest quarter, providing a clearer...
NYSE:BTGO
NYSE:BTGOCapital Markets

Bitgo Holdings (BTGO) Revenue Surge Tests Thin 0.5% Margin Narrative

Bitgo Holdings FY 2025 Earnings Snapshot Bitgo Holdings (BTGO) just posted its FY 2025 results with third quarter revenue of about US$5.8 billion, Basic EPS of US$0.19 and net income of US$6.8 million. Trailing twelve month revenue stood at roughly US$11.1 billion with Basic EPS of US$1.49 and net income of US$57.1 million. The company has seen quarterly revenue move from US$817.8 million in FY 2024 Q3 to US$5.8 billion in FY 2025 Q3, and Basic EPS shift from US$0.11 in FY 2024 Q1 and Q2 to...
NasdaqGS:STRS
NasdaqGS:STRSReal Estate

Stratus Properties (STRS) Q3 Loss Deepens And Reinforces Bearish Profitability Narrative

Stratus Properties (STRS) has just posted another tough quarter, with Q3 FY 2025 revenue of US$5.0 million and a basic EPS loss of US$0.62, alongside a net income loss of US$5.0 million. The trailing twelve month picture shows total revenue of US$31.9 million and a net income loss of US$8.1 million. Over recent periods the company has seen quarterly revenue move between US$4.9 million and US$11.6 million, with basic EPS ranging from a small profit of US$0.03 per share to losses of up to...
NYSE:TDW
NYSE:TDWEnergy Services

Is Tidewater (TDW) Pricing Reflect Its Surge After Recent Energy Services Sector Focus

If you are wondering whether Tidewater's current share price really reflects its underlying worth, you are not alone. The stock last closed at US$82.40, with returns of 13.7% over 7 days, 4.9% over 30 days, 57.8% year to date, and 89.6% over 1 year that many investors will be paying close attention to. Recent news coverage has focused on Tidewater's role within the energy services space and how investors are reacting to sector wide sentiment. This context helps frame why the recent price...
NasdaqCM:CV
NasdaqCM:CVMedical Equipment

CapsoVision (CV) Q4 Loss Of US$0.16 EPS Tests Bullish Profitability Narratives

CapsoVision (CV) closed FY 2025 with fourth quarter revenue of US$3.9 million, a basic EPS loss of US$0.16 per share, and trailing twelve month revenue of US$13.6 million alongside a trailing EPS loss of US$1.03 per share. Over recent quarters, revenue has moved from US$3.5 million in Q3 2025 and US$3.3 million in Q2 2025 to the latest US$3.9 million print. Basic EPS losses shifted from US$0.17 and US$2.02 over those same periods to US$0.16, leaving investors focused on how quickly margins...
NYSE:CCL
NYSE:CCLHospitality

Carnival Corporation (CCL) 10.4% Net Margin Strengthens Bullish Earnings Narrative

Carnival Corporation (CCL) has kicked off Q1 2026 following a solid run through 2025, with Q4 2025 revenue of US$6.3 billion, basic EPS of US$0.32 and net income of US$422 million framing the latest set of numbers. Over the past few quarters, revenue has moved from US$5.9 billion in Q4 2024 to US$6.3 billion in Q2 2025 and again US$6.3 billion in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.06 in Q1 2025 to US$1.41 in Q3 2025. This has set up a story where rising trailing...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Is Solventum (SOLV) Offering Value After Recent 16% Monthly Share Price Slide

If you are wondering whether Solventum's current share price still reflects its underlying worth, you are not alone. Many investors are asking the same question as they reassess what counts as good value in healthcare. Over the past month, Solventum's share price moved from recent levels to close at US$62.76, with a 7 day return of a 4.6% decline and a 30 day return of a 16.4% decline that adds to a 20.6% decline year to date and a 16.0% decline over the last year. These moves have come as...
NasdaqCM:SKYX
NasdaqCM:SKYXElectrical

SKYX Platforms (SKYX) Q4 Loss Narrows To US$0.07 EPS And Tests Bearish Profitability Views

SKYX Platforms (SKYX) closed out FY 2025 with Q4 revenue of about US$24.9 million, a basic EPS loss of US$0.07, and a net income loss of roughly US$8.2 million, while the trailing twelve months showed revenue of about US$92.0 million against a net loss of around US$34.5 million and basic EPS of US$0.32 in losses. Over recent quarters the company has seen revenue move from roughly US$23.7 million in Q4 2024 to US$24.9 million in Q4 2025. Quarterly basic EPS losses shifted from about US$0.11 to...
NasdaqGS:VFS
NasdaqGS:VFSAuto

Is It Time To Reassess VinFast Auto (VFS) After Recent Share Price Rebound?

If you are wondering whether VinFast Auto's current share price really reflects what the business is worth, you are not alone. That is exactly what this valuation focused review will tackle. The stock recently closed at US$3.39, with returns of 18.5% over 7 days, 2.7% over 30 days, 0.3% year to date and 0.0% over the last year, alongside a 67.0% decline over 3 years. Recent headlines around VinFast Auto have continued to keep the company on investors' radar and have added fresh context to...